
Brazilian Rare Earths Ltd (ASX: BRE) secured a key approval this week, with the Brazilian Government granting the company a trial mining licence for the “ultra-high grade” Monte Alto rare earth and critical minerals project the company is developing.
The team at Canaccord Genuity has had a look at the announcement, and while they haven’t changed their target price on the company, the target is still well above the current share price of $4.30. More on that later.
Major news
Firstly, what did the company itself say this week?
Brazilian Rare Earths said the newly-granted licence allows it to extract up to 2000 tonnes per year of product from the Monte Alto deposit, “enabling BRE to produce bulk shipments for potential customer offtakes and metallurgical testing at its Camaçari pilot plant”.
Trial mining at Monte Alto will also support the commissioning and operation of the company’s fully permitted pilot plant, which remains on schedule to start operations in the third quarter of 2026.
Brazilian Rare Earths managing director Bernardo da Veiga said:
Securing the Trial Mining Licence is a significant milestone for Monte Alto and a major step forward in BRE’s integrated ore-to-oxides development pathway in Brazil. This approval reflects the strength of our permitting work, the quality of our engagement with local communities and government stakeholders, and the advantages of Monte Alto’s deliberately low-impact development model. With ultra-high-grade mineralisation, dry processing and a quarry-scale operating model, Monte Alto has been designed from the outset to support a staged, capital-efficient path through permitting and development. Just as importantly, trial mining can now supply high-grade material for customer evaluation and for our fully permitted pilot plant at Camaçari, linking upstream production with downstream processing capability in Brazil. That integrated model is central to our strategy to rebuild a leading Brazilian rare earths and critical minerals supply chain.
Shares looking cheap
Canaccord said it continued to look towards the publication of a maiden mineral resource estimate as a key valuation catalyst for the company.
As a recap, our modelled development scenario is based on an assumed Mining Inventory of just 3 million tonnes of ultra high grade primary material, which ⦠supports a 10-year project at 7ktpa NdPr oxides through an integrated mine + refinery development. A larger mineral resource estimate would clearly support a longer mine life, in our view.
Canaccord has a speculative buy rating on Brazilian Rare Earths shares and price target of $8, which is 86% higher than the current share price.
The ASX rare earths company was valued at $1.24 billion at the close of trade on Wednesday.
The post Following a key approval, one broker tips 80% upside for this ASX rare earths stock appeared first on The Motley Fool Australia.
Should you invest $1,000 in Brazilian Rare Earths right now?
Before you buy Brazilian Rare Earths shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Brazilian Rare Earths wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Why 4DMedical, Brazilian Rare Earths, Clarity, and Tuas shares are racing higher today
- Why is this ASX rare earths stock storming 7% higher today?
- 4 cheap Aussie rare earths companies which are worth a look, according to Wilsons Advisory
- Up 139% in a year, why this buy rated ASX All Ords rare earths stock could keep racing higher
- Top broker names 3 ASX rare earths stocks to buy
Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.